Skip to main content

Peer Review reports

From: Oral nicotinamide mononucleotide (NMN) to treat chronic insomnia: protocol for the multicenter, randomized, double-blinded, placebo-controlled trial

Original Submission
22 Jul 2022 Submitted Original manuscript
19 Sep 2022 Reviewed Reviewer Report - Xiangji Ying
2 Dec 2022 Author responded Author comments - Xiangyang Gao
Resubmission - Version 2
2 Dec 2022 Submitted Manuscript version 2
7 Dec 2022 Reviewed Reviewer Report - Xiangji Ying
30 Jan 2023 Author responded Author comments - Xiangyang Gao
Resubmission - Version 3
30 Jan 2023 Submitted Manuscript version 3
4 Feb 2023 Reviewed Reviewer Report - Xiangji Ying
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
20 Apr 2023 Editorially accepted
18 May 2023 Article published 10.1186/s13063-023-07351-8

You can find further information about peer review here.

Back to article page